BeyondSpring Inc. Insider Trading

BYSI

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

No executive or director has bought shares on the open market in the last two years.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

None

in the last two years

Get an email when BYSI's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 16, 2025 – Oct 17, 2025	Decheng Capital China Life Sciences USD Fund II, L.p. Large holder	SoldNo plan 2 parts	131,311	$1.73 average	228K	3.2%	Form 4
Oct 13, 2025 – Oct 15, 2025	Decheng Capital Global Healthcare GP, LLC Large holder	SoldNo plan 3 parts	153,816	$1.68 average	259K	3.6%	Form 4
Oct 8, 2025 – Oct 10, 2025	Decheng Capital Global Healthcare GP, LLC Large holder	SoldNo plan 3 parts	13,876	$1.78 average	25K	0.3%	Form 4
Oct 3, 2025 – Oct 7, 2025	Decheng Capital Management III (cayman), LLC Large holder	SoldNo plan 3 parts	20,200	$1.78 average	36K	0.5%	Form 4
Sep 30, 2025 – Oct 2, 2025	Xiangmin Cui Large holder	SoldNo plan 3 parts	7,665	$1.80 average	14K	0.2%	Form 4
Sep 25, 2025 – Sep 29, 2025	Decheng Capital Management III (cayman), LLC Large holder	SoldNo plan 3 parts	1,800	$1.69 average	3K	<0.1%	Form 4
Sep 22, 2025 – Sep 24, 2025	Decheng Capital Global Healthcare GP, LLC Large holder	SoldNo plan 3 parts	11,772	$1.76 average	21K	0.3%	Form 4
Sep 17, 2025 – Sep 19, 2025	Decheng Capital Global Healthcare GP, LLC Large holder	SoldNo plan 3 parts	11,267	$1.77 average	20K	0.3%	Form 4
Sep 12, 2025 – Sep 16, 2025	Decheng Capital Global Healthcare Fund (master), LP Large holder	SoldNo plan 3 parts	4,110	$1.85 average	8K	<0.1%	Form 4
Sep 9, 2025 – Sep 11, 2025	Decheng Capital Management III (cayman), LLC Large holder	SoldNo plan 3 parts	21,046	$1.94 average	41K	0.5%	Form 4
Sep 4, 2025 – Sep 8, 2025	Decheng Capital Management III (cayman), LLC Large holder	SoldNo plan 3 parts	8,999	$1.91 average	17K	0.2%	Form 4
Aug 29, 2025 – Sep 3, 2025	Xiangmin Cui Large holder	SoldNo plan 3 parts	4,870	$1.78 average	9K	0.1%	Form 4
Aug 26, 2025 – Aug 28, 2025	Decheng Capital China Life Sciences USD Fund II, L.p. Large holder	SoldNo plan 3 parts	4,109	$1.79 average	7K	<0.1%	Form 4
Aug 21, 2025 – Aug 25, 2025	Decheng Capital Global Healthcare Fund (master), LP Large holder	SoldNo plan 3 parts	5,710	$1.77 average	10K	0.1%	Form 4
Aug 18, 2025 – Aug 20, 2025	Decheng Capital China Life Sciences USD Fund II, L.p. Large holder	SoldNo plan 3 parts	54,728	$1.99 average	109K	1.2%	Form 4
Aug 14, 2025 – Aug 15, 2025	Xiangmin Cui Large holder	SoldNo plan 2 parts	4,900	$2.00 average	10K	0.1%	Form 4
Jun 17, 2025 – Aug 4, 2025	Xiangmin Cui Large holder	SoldNo plan 17 parts	394,436	$3.05 average	$1.2M	8.1%	Form 4

Oct 16, 2025 – Oct 17, 2025No plan
Decheng Capital China Life Sciences USD Fund II, L.p.
Large holder · sold 131,311 at avg $1.73
228K
3.2% of stake
Oct 13, 2025 – Oct 15, 2025No plan
Decheng Capital Global Healthcare GP, LLC
Large holder · sold 153,816 at avg $1.68
259K
3.6% of stake
Oct 8, 2025 – Oct 10, 2025No plan
Decheng Capital Global Healthcare GP, LLC
Large holder · sold 13,876 at avg $1.78
25K
0.3% of stake
Oct 3, 2025 – Oct 7, 2025No plan
Decheng Capital Management III (cayman), LLC
Large holder · sold 20,200 at avg $1.78
36K
0.5% of stake
Sep 30, 2025 – Oct 2, 2025No plan
Xiangmin Cui
Large holder · sold 7,665 at avg $1.80
14K
0.2% of stake
Sep 25, 2025 – Sep 29, 2025No plan
Decheng Capital Management III (cayman), LLC
Large holder · sold 1,800 at avg $1.69
3K
<0.1% of stake
Sep 22, 2025 – Sep 24, 2025No plan
Decheng Capital Global Healthcare GP, LLC
Large holder · sold 11,772 at avg $1.76
21K
0.3% of stake
Sep 17, 2025 – Sep 19, 2025No plan
Decheng Capital Global Healthcare GP, LLC
Large holder · sold 11,267 at avg $1.77
20K
0.3% of stake
Sep 12, 2025 – Sep 16, 2025No plan
Decheng Capital Global Healthcare Fund (master), LP
Large holder · sold 4,110 at avg $1.85
8K
<0.1% of stake
Sep 9, 2025 – Sep 11, 2025No plan
Decheng Capital Management III (cayman), LLC
Large holder · sold 21,046 at avg $1.94
41K
0.5% of stake
Sep 4, 2025 – Sep 8, 2025No plan
Decheng Capital Management III (cayman), LLC
Large holder · sold 8,999 at avg $1.91
17K
0.2% of stake
Aug 29, 2025 – Sep 3, 2025No plan
Xiangmin Cui
Large holder · sold 4,870 at avg $1.78
9K
0.1% of stake
Aug 26, 2025 – Aug 28, 2025No plan
Decheng Capital China Life Sciences USD Fund II, L.p.
Large holder · sold 4,109 at avg $1.79
7K
<0.1% of stake
Aug 21, 2025 – Aug 25, 2025No plan
Decheng Capital Global Healthcare Fund (master), LP
Large holder · sold 5,710 at avg $1.77
10K
0.1% of stake
Aug 18, 2025 – Aug 20, 2025No plan
Decheng Capital China Life Sciences USD Fund II, L.p.
Large holder · sold 54,728 at avg $1.99
109K
1.2% of stake
Aug 14, 2025 – Aug 15, 2025No plan
Xiangmin Cui
Large holder · sold 4,900 at avg $2.00
10K
0.1% of stake
Jun 17, 2025 – Aug 4, 2025No plan
Xiangmin Cui
Large holder · sold 394,436 at avg $3.05
$1.2M
8.1% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BYSI, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with BYSI

CompareIntrinsic value

CAPRCapricor Therapeutics Inc.

$8.92+8.25%10

MGNXMacrogenics Inc.

$2.31-0.86%36

VREOFVireo Growth Inc.

$7.29-2.15%30

NKTRNektar Therapeutics Inc.

$38.48+1.91%25

PTIXProtagenic Therapeutics, Inc.

$0.65+4.84%20

ABBVAbbVie Inc.

$294.83+3.09%49

SKVISkinvisible Inc.

$0.16+0.00%0

SILOSilo Pharma Inc.

$1.33+3.91%10

Spot a number that looks wrong? Check it in BYSI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BYSI

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.